Bringing a Segmentation to Life with AI
Bringing a Segmentation to Life with AI The Opportunity The market for continuous glucose monitors (CGMs) was evolving fast. Once used mostly by insulin-dependent diabetics, CGMs were gaining traction in the mainstream—driven by influencers and the “quantified self” movement. Dexcom aimed to lead this shift with Stelo, a prescription-free CGM. Designed for adults with type…












